ROBERT E. CONWAY - 13 May 2021 Form 4 Insider Report for ARCA biopharma, Inc. (ORKA)

Role
Director, Chairman of the Board
Signature
/s/ C. Jeffrey Dekker, Attorney-in-Fact
Issuer symbol
ORKA
Transactions as of
13 May 2021
Net transactions value
+$31,947
Form type
4
Filing time
13 May 2021, 17:00:43 UTC
Next filing
23 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABIO Common Stock Purchase $31,947 +10,000 +25% $3.19 50,000 12 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $3.18 to $3.20. Upon request of the SEC staff, ARCA biopharma, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased at each separate price.